Drug Repurposing
Table of Contents
Introduction
Drug repurposing, also known as drug repositioning, refers to the practice of identifying new therapeutic uses for existing drugs. This approach leverages the safety and efficacy data of previously approved or investigational compounds to accelerate the drug development process, reduce costs, and address unmet medical needs.
Definitions and Concepts
- Drug Repurposing (Repositioning): The process of finding new medical indications for approved or investigational drugs.
- High-throughput Screening: A technique that allows rapid testing of thousands of compounds for new biological activities.
- Computational Drug Repurposing: The use of bioinformatics, artificial intelligence, and data mining to predict new drug-disease associations.
- Phenotypic Screening: The process of observing the effects of compounds in cell-based or animal models without prior knowledge of their mechanism of action.
Importance
Drug repurposing plays a crucial role in modern drug development for several reasons:
- Time and Cost Efficiency: Since repurposed drugs have already undergone preclinical safety testing, they reduce the timeline and financial burden of drug development.
- Reduced Risk: Existing drugs have known pharmacokinetics, toxicity profiles, and side effects, making regulatory approval smoother.
- Addressing Rare and Neglected Diseases: Developing new treatments for rare diseases is often cost-prohibitive, but repurposing existing drugs offers a viable strategy.
- Emergency Situations and Pandemics: Drug repurposing has been instrumental in rapidly identifying potential treatments for outbreaks like COVID-19.
Principles or Methods
Several strategies are used to identify and validate new therapeutic applications for existing drugs:
- Computational Approaches: Using machine learning, network pharmacology, and molecular docking to predict new interactions and indications.
- Biological Screening: Testing drugs in different disease models to evaluate potential therapeutic activity.
- Target-Based Drug Repurposing: Identifying alternative targets for existing drugs by analyzing structural and mechanistic similarities.
- Clinical Observations and Real-World Data: Examining off-label drug use and real-world evidence to identify promising repurposing candidates.
- Combination Strategies: Exploring drug repurposing in combination with other drugs to enhance efficacy and expand treatment options.
Application
Drug repurposing is widely applied in various areas of life sciences, pharmaceuticals, and biotech, including:
- Oncology: Several non-cancer drugs, such as thalidomide and metformin, have been repurposed for cancer therapy.
- Neurology and Psychiatry: Drugs originally developed for cardiovascular diseases or infections have found applications in Alzheimer’s, Parkinson’s, and depression treatments.
- Infectious Diseases: Anti-malarial and antiviral drugs have been reutilized for diseases like COVID-19 and Ebola.
- Rare and Orphan Diseases: Many repurposed drugs provide treatment options for rare genetic disorders where no targeted therapy exists.